IRIS
FRONTONI, SIMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.064
AS - Asia 3.401
EU - Europa 2.712
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 50
OC - Oceania 11
Totale 35.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.970
SG - Singapore 1.761
CN - Cina 583
DE - Germania 404
RU - Federazione Russa 391
UA - Ucraina 386
IT - Italia 385
BR - Brasile 309
IE - Irlanda 287
HK - Hong Kong 286
VN - Vietnam 273
SE - Svezia 190
GB - Regno Unito 171
FR - Francia 162
FI - Finlandia 110
BD - Bangladesh 109
PL - Polonia 83
JP - Giappone 79
KR - Corea 79
IN - India 52
CA - Canada 45
AR - Argentina 33
NL - Olanda 31
ID - Indonesia 28
TR - Turchia 28
MX - Messico 25
AT - Austria 19
IQ - Iraq 18
ES - Italia 17
ZA - Sudafrica 15
BE - Belgio 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
UZ - Uzbekistan 11
EU - Europa 10
MY - Malesia 10
PK - Pakistan 10
PH - Filippine 9
RO - Romania 9
TH - Thailandia 9
AU - Australia 8
KE - Kenya 8
LT - Lituania 8
EC - Ecuador 7
IL - Israele 6
KG - Kirghizistan 6
VE - Venezuela 6
CH - Svizzera 5
EG - Egitto 5
JO - Giordania 5
MD - Moldavia 5
CR - Costa Rica 4
SA - Arabia Saudita 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
ET - Etiopia 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
MA - Marocco 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
PY - Paraguay 3
SV - El Salvador 3
TZ - Tanzania 3
BB - Barbados 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MK - Macedonia 2
PE - Perù 2
PR - Porto Rico 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 35.605
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.791
Wilmington 7.442
Houston 6.470
Fairfield 947
Singapore 862
Ashburn 629
Ann Arbor 623
Chandler 579
San Jose 368
Seattle 342
Jacksonville 334
Cambridge 297
Hong Kong 282
Dublin 259
Beijing 230
Medford 203
Dearborn 186
Council Bluffs 159
New York 138
Santa Clara 134
Los Angeles 128
The Dalles 109
Lawrence 91
Rome 86
Ho Chi Minh City 75
Tokyo 71
Buffalo 68
Hanoi 67
Kraków 61
Dallas 59
Lauterbourg 49
Moscow 41
Menlo Park 38
Helsinki 36
São Paulo 36
Mülheim 35
Nuremberg 34
San Diego 33
Milan 32
Boardman 28
Munich 28
Falls Church 27
London 24
Phoenix 24
Palo Alto 23
Frankfurt am Main 22
Nanjing 21
Chicago 20
Jakarta 20
Boston 19
Orem 19
Redwood City 19
Zhengzhou 19
Columbus 18
Norwalk 18
Brooklyn 17
Mountain View 17
San Mateo 17
Dong Ket 16
Guangzhou 16
Haiphong 16
Warsaw 16
Chennai 15
Montreal 14
Redondo Beach 14
Brussels 13
Shanghai 13
Verona 13
Chengdu 12
Kunming 12
Nürnberg 12
Atlanta 11
Brno 11
Toronto 11
Indiana 10
Manchester 10
Philadelphia 10
San Francisco 10
Ankara 9
Da Nang 9
Detroit 9
Hefei 9
Mexico City 9
Minneapolis 9
Seoul 9
Stockholm 9
University Park 9
Boydton 8
Hangzhou 8
Johannesburg 8
Auburn Hills 7
Baghdad 7
Bangkok 7
Belo Horizonte 7
Brasília 7
Charlotte 7
Creede 7
Nairobi 7
Poplar 7
Rio de Janeiro 7
Totale 30.254
Salva come PNG Salva come JPEG
Nome #
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 560
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management 555
Insulin clearance is associated with carotid artery intima-media thickness 554
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients 519
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments 510
Assessment of sympathetic innervation of the heart in diabetes mellitus using 123I-MIBG 505
The social burden of hypoglycemia in the elderly 484
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit 482
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 481
Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes 480
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 479
Relationship between autonomic neuropathy, 24-h blood pressure profile, and nephropathy in normotensive IDDM patients 473
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 472
Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria 472
Differences in insulin clearance between metabolically healthy and unhealthy obese subjects 471
Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy 469
Preliminary evidence that obese patients with obstructive sleep apnea/hypopnea syndrome are refractory to the acute beneficial metabolic effects of a very low calorie diet 466
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases [Linee Guida per la concessione dell'idoneità all'attività sportiva ed il monitoraggio degli atleti affetti da malattie del sistema endocrino] 457
Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes 456
Carbohydrate metabolism in hypertension: influence of treatment 452
Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients 451
Intravenous dexamethasone and subsequent ACTH test in comparison with dexamethasone oral test in the diagnosis of Cushing's syndrome: a report of 20 cases 450
Regression of microalbuminuria in type II diabetic,hypertensive patients after long-term indapamide treatment 447
Comment on: Inzucchi et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364-1379. 445
Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability 444
Polymorphisms of the insulin receptor subtrate-2 in patients with type 2 diabetes 443
Position Statement on the management of continuous subcutaneous insulin infusion (CSII): The Italian Lazio experience 443
The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes 435
The DAWN Youth WebTalk Study: methods, findings, and implications. 434
Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals 433
Methods of investigation for cardiac autonomic dysfunction in human research studies 431
Effects of beta-adrenergic blockade on insulin-mediated glucose disposal in hypertensive and normotensive rats 429
Evaluation of guidelines on diabetes medication. 423
Acute hyperglycemia reduces cerebrovascular reactivity: The role of glycemic variability 423
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 423
Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives. 421
The Arg972 variant in insulin receptor substrate-1 is associated with an atherogenic profile in offspring of type 2 diabetic patients 420
Insulin sensitivity, and β-cell function in relation to hemoglobin A1C 419
Hyperinsulinaemia in offspring of Type 2 diabetic patients: impaired response of carbohydrate metabolism, but preserved cardiovascular response 418
Hyperinsulinemia and insulin resistance are independently associated with plasma lipids, uric acid and blood pressure in non-diabetic subjects: the GISIR database 418
C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance 416
Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. 411
Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. 407
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 406
Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease 404
The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: A neutral viewpoint 404
SYMPTOMATIC TREATMENT OF AUTONOMIC NEUROPATHY IN DIABETIC SUBJECTS 403
Single retinal layer evaluation in patients with type 1 diabetes with no or early signs of diabetic retinopathy: The first hint of neurovascular crosstalk damage between neurons and capillaries? 400
The need for identifying standardized indices for measuring glucose variability. 399
Mancato effetto dell’iperinsulinemia esogena sui valori della pressione arteriosa e sull’attività simpatica nei soggetti con diabete di tipo 1 e neuropatia autonomica 396
Glucose variability: An emerging target for the treatment of diabetes mellitus 395
Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography 395
Bariatric surgery or medical therapy for obesity 394
Effect of the GSTM1 gene deletion on glycemic variability, sympatho-vagal balance and arterial stiffness in patients with metabolic syndrome, but without diabetes 394
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 391
The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes 387
Continuous Subcutaneous Insulin Infusion (CSII) in Inpatient Setting: Unmet Needs and the Proposal of a CSII Unit. 387
Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes 382
Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients 382
Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? 382
Metabolic syndrome in subjects at high risk for type 2 diabetes: The genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study. 378
Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women 372
Guidelines for the eligibility to sports activities and the monitoring of athletes with endocrine diseases 372
Twenty-four hours blood pressure and heart rate profiles in diabetics with and without autonomic neuropathy 368
QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA 366
Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance. 365
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial 358
Correspondence between the international diabetes federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic caucasians: The GISIR database [4] 356
Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels 342
Effects of insulin on cholesterol synthesis in type II diabetes patients 341
Neuroretinal dysfunction is associated with early peripheral motor unit loss in type 1 diabetes 340
Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus 338
Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes 335
Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion 330
La terapia insulinica aumenta il rischio cardiovascolare? 306
Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study. 304
Activation of retinal Müller cells in response to glucose variability 286
Flavonoids and insulin-resistance: from molecular evidences to clinical trials 285
Rapid and easy assessment of insulin resistance contributes to early detection of polycystic ovary syndrome 282
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 270
Neuroretinal Dysfunction Is Associated with Early Peripheral Motor Unit Loss in Type 1 Diabetes Mellitus 269
Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus 266
Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting 255
Neuropathic damage in the diabetic eye: clinical implications 207
Early alterations of corneal subbasal plexus in uncomplicated type 1 diabetes patients 204
Urban diabetes: the case of the metropolitan area of Rome 190
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes: A consensus view of Italian diabetes experts using the Delphi method 147
Urban diabetes: the case of the metropolitan area of Rome 138
Correction: Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-Determination: the Italian Road to Bariatric Surgery 125
The evaluation of tactile dysfunction in the hand in type 1 diabetes: a novel method based on haptics 109
Autonomic Nervous System in Obesity and Insulin-Resistance-The Complex Interplay between Leptin and Central Nervous System 100
Glycemic status assessment by the latest glucose monitoring technologies 96
Microvascular impairment as a biomarker of diabetic retinopathy progression in the long-term follow up in type 1 diabetes 94
Gliotic Response and Reprogramming Potential of Human Müller Cell Line MIO-M1 Exposed to High Glucose and Glucose Fluctuations 87
Subcutaneous insulin infusion (CSII) in italy: The third national survey 86
Advice of General Practitioner, of Surgeon, of Endocrinologist, and Self-determination: the Italian Road to Bariatric Surgery 84
Outer retina dysfunction and choriocapillaris impairment in type 1 diabetes 82
Metformin Benefits: Another Example for Alternative Energy Substrate Mechanism? 74
MG53 marks poor beta cell performance and predicts onset of type 2 diabetes in subjects with different degrees of glucose tolerance 72
Knowledge, experiences, and perceptions relating to obesity management among primary care physicians in the Lazio Region, Italy 64
Totale 35.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 82.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 82.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022971 0 106 75 46 52 105 44 55 47 93 53 295
2022/20231.406 137 107 68 186 150 298 123 80 149 3 65 40
2023/2024361 38 12 29 12 39 111 27 17 6 9 5 56
2024/20252.453 104 510 251 131 53 105 200 112 199 137 324 327
2025/20263.711 338 199 465 286 286 113 429 449 421 316 174 235
2026/2027399 190 209 0 0 0 0 0 0 0 0 0 0
Totale 35.867